Some consumers take tiny doses of Ozempic and other GLP-1 drugs or stretch out doses to cut costs and side effects.

According to the Market Research Blog, "the total U.S. weight loss market is estimated to have grown to a historic peak of ...

VinFuture Prize holds the distinction of being the first major international science and technology award to recognize and ...

Victoza has been largely superseded by Novo Nordisk's once-weekly therapy Ozempic (semaglutide), with sales falling 41% in the first nine months of this year to $571 million as Ozempic rose by a ...

Novo Nordisk's GLP-1 receptor agonist semaglutide ... which is already seeing sales rocket on the back of its use as Ozempic for diabetes, Wegovy for obesity, and label extensions for both brands ...

Novo's Wegovy has lost market share to Eli Lilly's Zepbound, and a new head-to-head study found that Zepbound patients lost ...

The FDA is cracking down on off brand weight loss products similar to Ozempic. GLP-1 drugs for weight loss like Wegovy or ...